Bilbo Patrick's most recent trade in Organogenesis Holdings Inc - Ordinary Shares - Class A was a trade of 190,475 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 190,475 | 190,475 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 184,136 | 949,062 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 25,739 | 769,599 (0%) | 0% | 3.7 | 95,234 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 13,744 | 795,338 (0%) | 0% | 3.7 | 50,853 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 3,883 | 765,716 (0%) | 0% | 3.7 | 14,367 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 790 | 764,926 (0%) | 0% | 3.7 | 2,923 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 01 Apr 2024 | 2,497 | 809,082 (0%) | 0% | 2.8 | 6,992 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2024 | 152,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. | 28 Mar 2024 | 152,250 | 811,579 (0%) | 0% | 1.2 | 179,655 | Class A Common Stock |
| Organogenesis Holdings Inc... | Bilbo Patrick | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 338,674 | 338,674 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Bilbo Patrick | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 187,318 | 659,329 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 15 Feb 2024 | 24,925 | 477,410 (0%) | 0% | 3.7 | 91,724 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 15 Feb 2024 | 4,608 | 472,802 (0%) | 0% | 3.7 | 16,957 | Class A Common Stock |
| Organogenesis Holdings Inc... | Bilbo Patrick | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.48 per share. | 15 Feb 2024 | 791 | 472,011 (0%) | 0% | 3.5 | 2,753 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 01 Apr 2023 | 2,678 | 502,335 (0%) | 0% | 2.1 | 5,704 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 388,654 | 388,654 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 327,386 | 505,013 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.92 per share. | 15 Feb 2023 | 4,599 | 178,563 (0%) | 0% | 2.9 | 13,429 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 Feb 2023 | 936 | 177,627 (0%) | 0% | 2.8 | 2,574 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.89 per share. | 01 Apr 2022 | 2,497 | 183,162 (0%) | 0% | 7.9 | 19,701 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 125,522 | 125,522 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 52,926 | 186,596 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.78 per share. | 15 Feb 2022 | 937 | 185,659 (0%) | 0% | 7.8 | 7,290 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2021 | 30,450 | 0 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 10 Nov 2021 | 30,450 | 133,670 (0%) | 0% | 1.4 | 43,848 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.83 per share. | 01 Apr 2021 | 2,497 | 164,120 (0%) | 0% | 19.8 | 49,516 | Class A Common Stock |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 82,556 | 82,556 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Patrick Bilbo | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 10,782 | 166,617 (0%) | 0% | 0 | Class A Common Stock |